US20120107431A1 - Cosmetic composition containing a rubus coreanus extract for diminishing skin wrinkles - Google Patents

Cosmetic composition containing a rubus coreanus extract for diminishing skin wrinkles Download PDF

Info

Publication number
US20120107431A1
US20120107431A1 US13/381,784 US201013381784A US2012107431A1 US 20120107431 A1 US20120107431 A1 US 20120107431A1 US 201013381784 A US201013381784 A US 201013381784A US 2012107431 A1 US2012107431 A1 US 2012107431A1
Authority
US
United States
Prior art keywords
extract
rubus
rubus coreanus
cosmetic composition
skin wrinkles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/381,784
Other languages
English (en)
Inventor
Dong Hyun Kim
Jun Seong Park
Sun Hye Yu
Dae Hyuk Kweon
Hyun Ju Koh
Won Seok Park
Duck Hee Kim
Han Kon Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amorepacific Corp
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Assigned to AMOREPACIFIC CORPORATION reassignment AMOREPACIFIC CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KIM, DONG HYUN, KIM, DUCK HEE, KIM, HAN KON, KOH, HYUN JU, KWEON, DAE HYUK, PARK, JUN SEONG, PARK, WON SEOK, YU, SUN HYE
Publication of US20120107431A1 publication Critical patent/US20120107431A1/en
Priority to US13/778,176 priority Critical patent/US9198945B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Definitions

  • the present invention relates to a cosmetic composition containing a Rubus coreanus extract as an active ingredient, and more particularly to a cosmetic composition containing an extract from Rubus coreanus processed by traditional oriental medicinal processing technology, in which the Rubus coreanus extract has an excellent effect of reducing skin wrinkles by inhibiting the formation of SNARE complexes and the release of a neurotransmitter.
  • the cosmetic composition has excellent stability in formulations compared to conventional products for reducing skin wrinkles and exhibit effects similar to Botox which has been used to reduce skin wrinkles, thereby greatly reducing skin wrinkles without causing adverse effects.
  • a synaptic vesicle containing the neurotransmitter is required to be fused with a presynaptic membrane so that a passage between two boundaries can be formed.
  • a fundamental force for such membrane fusion is provided by SNARE complexes comprising three kinds of proteins.
  • SNARE complexes comprising three kinds of proteins.
  • Such SNARE proteins are twisted in a spiral shape. In the membrane fusion, rearrangement of a lipid bilayer, which is widely known in the art, occurs. Since biomembranes strongly repel against each other, the membranes cannot be automatically merged, and thus a strong external force is required to overcome the repulsive force between the membranes. Herein, SNARE proteins generate such a strong force enough to overcome the repulsive force between the membranes. In other words, the formation of a SNARE complex is a force generator to overcome a repulsive power between membranes, and a main action in exocytosis including release of a neurotransmitter.
  • BoNT Botulinum neurotoxin
  • Botox is a protease for cleavage of a SNARE protein, which is a main protein involved in the release of a neurotransmitter. Botox cleaves a SNARE protein to block neurotransmission, which results in paralysis of Botox-penetrated muscle cells.
  • Botox irreversibly cleaves the SNARE protein to blocks neurotransmission
  • so-called “applicable Botox” is a kind of competitive inhibitor that inhibits the formation of a SNARE complex to interfere with neurotransmission.
  • Argireline that is the main component of an applicable botox product currently has disadvantages in that its effect is not reliable, its price is unfavorable due to the characteristics of the synthetic peptide and it is not consumer-friendly.
  • Developing a neurotransmission inhibitor based on a natural extract can provide a raw material that is significantly inexpensive compared to a peptide material, and a final product produced from the natural extract is consumer-friendly.
  • the natural extract is easily industrially applied compared to peptide materials.
  • a medicinal herb processing technique that is a traditional oriental medicine manufacturing technique is called “Po-je”, “Hap-hwa”, “Hap-yak”, “Su-chi”, “Po-ja”, “Beob-je” and “Su-sa” in Korean.
  • This technique can be defined as a medicine manufacturing technique of changing the inherent properties of medicinal herbs by processing the medicinal herbs on the basis of the oriental medicine theory.
  • the processing of medicinal herbs includes selection of correct medicine, removal of impurities, purification, heating, processing employing aids, etc.
  • medicinal herbs are processed together with aids suitable for medical applications in order to achieve the administration of medicine according to disease.
  • aids are used in the processing of medicinal herbs, they have different properties and effects, and thus the processed medicinal herbs show different effects.
  • Aids which are currently used in the processing of medicinal herbs are various and broadly divided into liquid aids and solid aids.
  • the liquid aids include liquor, vinegar, brine, honey, ginger juice, licorice juice, black bean juice, saline solution, rice water, horse oil, milk, children urine, and lime water.
  • the solid aids include rice, wheat bran, alum, bean-curd, soil, seashell powder, and sand.
  • the processing medicinal herbs is carried out to clarify medicines, facilitate the storage of medicines, reduce or remove the toxicity or side effects of medicines, change the properties of medicines to make the medicines more effective, enhance the therapeutic effects of medicines, and the offensive odor and taste of medicines to facilitate the intake of the medicines.
  • Skin wrinkles are the most noticeable sign of skin aging which occurs due to intrinsic factors, such as aging and stress, or external environmental factors such as air pollution and UV radiation. Wrinkles occur on facial areas, such as the forehead, eye rims, eyebrow, and peri-oral areas, and various portions of the body, such as a neck, neck circumferences, elbows, armpits, hands, and feet. Wrinkles generally start to become visible after about 30 years old, and the number or depth thereof increase with aging. Such wrinkles are considered to occur mainly because reactive oxygen species produced in skin tissues by a skin aging crosslink collagen fibers and elastic fibers forming the majority of the skin dermis to change the production and degradation of such fibers.
  • Antioxidants such as vitamin E, beta-carotene, vitamin C and glutathione, which are used to inhibit skin aging, radical scavengers, or substances such as vitamin A, which increase the synthesis of dermal collagen, have been used to reduce skin wrinkles.
  • cosmetic active ingredients have disadvantages in that they are mostly strongly irritating to the skin or are unstable in formulations to cause discoloration, bad smell and precipitation, and the inherent activity thereof decreases.
  • the present inventors have conducted studies on natural materials having an excellent effect of reducing skin wrinkles and, as a result, have found that a cosmetic composition comprising a Rubus coreanus extract have an excellent effect of reducing skin wrinkles, thereby completing the present invention.
  • an object of the present invention to provide a cosmetic composition containing a Rubus coreanus extract as an active ingredient.
  • the present invention provides a cosmetic composition containing a Rubus coreanus extract as an active ingredient.
  • the cosmetic composition according to the present invention contains as an active ingredient a Rubus coreanus extract which inhibits the formation of a SNARE complex and prevents the release of a neurotransmitter, thereby exhibiting an excellent effect of reducing skin wrinkles. Also, because the cosmetic composition of the present invention contains the natural material, it has reduced adverse effects on the skin and has reduced skin irritation. In addition, it has high stability in formulations compared to conventional agents for reducing skin wrinkles, and shows effects similar to Botox which has been used to reduce wrinkles, thereby significantly reducing skin wrinkles without causing adverse effects.
  • FIG. 1 is a graphic diagram showing the inhibitory effect of a Rubus coreanus extract according to the present invention on the membrane fusion phenomenon.
  • FIG. 2 is a graphic diagram showing the inhibitory effect of a Rubus coreanus extract according to the present invention on the release of a neurotransmitter in PC12 cells.
  • the present invention provides a composition for reducing skin wrinkles which contains a Rubus coreanus extract as an active ingredient.
  • Rubus coreanus that is used in the present invention is the fruit of Rubus coreanus Miguel and is odorless, sour and sweet in taste, and warm in nature. Rubus coreanus increases renal function and is thus used against involuntary ejaculation, wet dreams and enuresis. It also makes the body light and makes the hair black. It assists in pregnancy and makes the skin soft and beautiful. It was reported to have pharmacological activities, including anti-inflammatory, antioxidant effects and anti- Helicobacter pylori activities.
  • the Rubus coreanus extract of the present invention inhibits the formation of a SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex and the release of a neurotransmitter, thereby exhibiting an excellent of reducing skin wrinkles. It can show effects similar to Botox which has been used to reduce skin wrinkles, thereby significantly reducing skin wrinkles without causing adverse effects.
  • SNARE soluble N-ethylmaleimide-sensitive factor attachment protein receptor
  • Rubus coreanus may be processed before extraction with a solvent.
  • Dried Rubus coreanus is processed by a boiling process, a steaming process, a roasting process, a baking process, or a combination of two or more thereof.
  • Rubus coreanus is processed at 60 ⁇ 100° C. for 30 minutes to 2 hours for boiling, 120 ⁇ 150° C. for 3-6 hours for steaming, 100 ⁇ 180° C. for 10 minutes to 1 hour for roasting, and 80 ⁇ 100° C. for 10 minutes to 1 hour for baking. If the processing temperature and time are out of these ranges, the effect of processing Rubus coreanus will be insufficient or the components of Rubus coreanus can change.
  • Rubus coreanus may be processed together with an aid.
  • an aid that may be used in the present invention include liquor, vinegar, brine, honey, ginger juice, licorice juice, black bean juice, saline solution, rice water, horse oil, milk, children urine, lime water, rice, wheat bran, alum, bean-curd, soil, seashell powder, and sand.
  • a Rubus coreanus can be obtained by extracting the processed Rubus coreanus with water or an organic solvent under reflux, dipping the extract, filtering the dipped solution through filter cloth, centrifuging the filtered solution into residue and a filtrate, and concentrating the separated filtrate under reduced pressure.
  • Examples of an organic solvent that may be used in the present invention include ethanol, methanol, butanol, ether, ethyl acetate, chloroform, and a mixed solvent of at least one thereof with water. Preferably, 80% ethanol is used.
  • the extraction process is preferably carried out at a temperature of 10 ⁇ 80° C. for 6-24 hours. If the extraction temperature and time are out of these ranges, the efficiency of extraction will be insufficient or the components of Rubus coreanus can change.
  • the extract After the extract has been obtained using the solvent, it may be macerated at room temperature, heated and filtered, according to a conventional method in the art, thus obtaining a liquid material. Alternatively, it may be evaporated to remove the solvent or may be spray-dried or freeze-dried.
  • the cosmetic composition according to the present invention contains the Rubus coreanus extract in an amount of 0.0001-30 wt % based on the total weight of the composition. If the content of the Rubus coreanus extract is less than 0.0001 wt %, the effect of reducing skin wrinkles cannot be obtained, and if it is more than 30 wt %, an increase in the content will not lead to a significant increase in the effect thereof.
  • the cosmetic composition according to the present invention may be formulated into, but not limited to, skin lotion, astringent lotion, milk lotion, nourishing cream, massage cream, essence, pack, foundation, lipstick or powder foundation.
  • Components other than the extract in the cosmetic composition of the present invention can be suitably selected without difficulty by a person skilled in the art depending on the formulation or intended use of the cosmetic composition.
  • 1 kg of dried Rubus coreanus was immersed in 300 ml of yellow rice wine (aged in a Korean traditional pottery in the shade and used in an amount of 20-30 wt % based on the weight of dried Rubus coreanus ) for 1 hour so as to be wet with the yellow rice wine.
  • the wet Rubus coreanus was steamed in a steam pot at 10 ⁇ 150° C. for 4 hours, and then dried in the shade.
  • the dried material was added to 5 l of 80% ethanol aqueous solution, extracted three times under reflux, and then dipped at 15° C. for 1 day.
  • the dipped solution was filtered through filter cloth and centrifuged into residue and a filtrate, and the separated filtrate was concentrated under reduced pressure, thereby obtaining 260 g of an extract of wine-added steamed Rubus coreanus .
  • 1 kg of dried Rubus coreanus was mixed well with 200 ml of brine (aged in a Korean traditional pottery in the shade and having a salt concentration of 8-10% and also used in an amount of 20-30 wt % based on the weight of dried Rubus coreanus ) and allowed to stand for 1 hour in a closed state such that the brine was completely absorbed into the Rubus coreanus .
  • the brine-absorbed Rubus coreanus was put in a glass container, roasted at 150 for 30 minutes, and then dried in the shade. Then, the dried material was added to 5 l of 80% ethanol aqueous solution, extracted three times under reflux, and then dipped at 15° C. for 1 day. Next, the dipped solution was filtered through filter cloth and centrifuged into residue and a filtrate, and the separated filtrate was concentrated under reduced pressure, thereby obtaining 295 g of an extract of brine-added roasted Rubus coreanus.
  • SNARE proteins called SNAP25 (NMO11428), Syntaxin 1a (AF217197) and VAMP2 (NMO12663), respectively, were purified from E. coli Codon (+) RIL (Novagen) transformed by a biological technique.
  • a liposome that is a vesicle particle labeled with a fluorescent substance palmitoyloleoyl phosphatidylcholine (POPC) (62 mol %), dioleoyl phosphatidylserine (DOPS) (35 mol %), 1-oleoyl-2-[N-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]caproyl phosphatidylserine (NBD-PS) (1.5 mol %) and the fluorescent substance Rhodamin-PE (1.5 mol %) were mixed with each other to make 10 mM liposome (v-vesicle).
  • POPC palmitoyloleoyl phosphatidylcholine
  • DOPS dioleoyl phosphatidylserine
  • NBD-PS 1-oleoyl-2-[N-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino
  • DOPS and POPC were mixed with each other at a molar concentration of 35:65 to make 50 mM liposome (t-vesicle).
  • purified SNAP25 and Syntaxin 1a were mixed with each other at a molar concentration of 1:1 and allowed to react at room temperature for 1 hour, and then mixed with the non-fluorescence-labeled liposome at a molar ratio of 100:1, and VAMP2 was combined with the fluorescent substance-containing liposome at a molar ratio of 50:1.
  • the groups treated with the Rubus coreanu extracts showed excellent effects on the inhibition of membrane fusion compared to the control containing no Rubus coreanu extract.
  • the extract of wine-added, steamed Rubus coreanu (Example 3) had a significantly better effect on the inhibition of membrane fusion compared to the other Rubus coreanu extracts. This suggests that the Rubus coreanu extract of the present invention can exhibit an excellent effect of reducing skin wrinkles by effectively inhibiting the membrane fusion between SNARE proteins.
  • PC12 cells were cultured in Ham's F12K medium, containing 10% fetal calf serum, 5% fetal bovine serum and antibiotics, in a collagen-coated plate (60 mm dish). For subculture, the medium was sucked from the culture plate, after which 2 ml of PBS was added to the culture plate, and the cells were isolated from the dish wall by pipetting and centrifuged at 1,000 ⁇ g for 5 minutes. The cells were harvested, fresh medium was added thereto, and the cell pellets were dispersed by pipetting, added to a fresh culture plate and incubated in an incubator at 37 in the presence of 5% CO 2 gas. [ 3 H]-noradrenaline used in the test was purchased from Amersham.
  • the medium was sucked from the PC12 cell culture plate, PBS was added to the culture plate, and the cells were detached from the plate wall, after which the number of the cells was counted with a hemacytometer. Then, the cells were dispersed and inoculated in fresh medium at a concentration of 2 ⁇ 10 5 cells/Ml. After 24 hours, noradrenaline calibration buffer ([ 3 H]-NA, 1.5 ⁇ Ci/Ml) was added to the cells which were then incubated in a CO 2 gas incubator for 90 minutes. After incubation, the buffer was removed, after which the cells were washed three times with PBS.
  • noradrenaline calibration buffer [ 3 H]-NA, 1.5 ⁇ Ci/Ml
  • the cells were inoculated in fresh medium, and 10 ⁇ g/Ml of each of Rubus coreanu extracts of Examples 1 to 4 was added thereto and incubated for 30 minutes.
  • Verapamil was used and the cells were treated with Verapamil in the same manner as treatment with the Rubus coreanu extract.
  • high-concentration buffer was added to the cells which were then incubated in a CO 2 gas incubator for 12 minutes. Then, the supernatant was collected and measured with a scintillation counter to determine whether the release of [ 3 H]-noradrenaline was inhibited.
  • the Rubus coreanu extract of the present invention can exhibit an excellent effect of reducing skin wrinkles by inhibiting the release of a neurotransmitter.
  • a milk lotion containing an extract of wine-added steamed Rubus coreanu was prepared with the composition shown in Table 2 below.
  • a skin lotion containing an extract of wine-added steamed Rubus coreanu was prepared with the composition shown in Table 3 below.
  • a nourishing cream containing an extract of wine-added steamed Rubus coreanu was prepared with the composition shown in Table 4 below.
  • a massage cream containing an extract of wine-added steamed Rubus coreanu was prepared with the composition shown in Table 5 below.
  • the cosmetic composition of Formulation Example 3 containing the extract of wine-added steamed Rubus coreanu was applied to the wrinkled eye rims of ten women over 40-year-old (average age: 44.5 years old) twice a day for 12 weeks in an amount of 0.2 g each time.
  • T 0 the degree of reduction of skin wrinkles in the subjects
  • ⁇ W the degree of reduction of skin wrinkles in the subjects
  • Subjects T 0 T 12 Subject 1 0 2 Subject 2 0 3 Subject 3 0 3 Subject 4 0 2 Subject 5 0 2 Subject 6 0 2 Subject 7 0 2 Subject 8 0 2 Subject 9 0 1 Subject 10 0 3 ⁇ W(T 12 ⁇ T 0 ) 2.0

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
US13/381,784 2009-06-25 2010-06-25 Cosmetic composition containing a rubus coreanus extract for diminishing skin wrinkles Abandoned US20120107431A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/778,176 US9198945B2 (en) 2009-06-25 2013-02-27 Cosmetic compositoin containing a rubus coreanus extract for diminishing skin wrinkles

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20090058901 2009-06-30
KR10-2009-0058901 2009-06-30
PCT/KR2010/004144 WO2011002179A2 (ko) 2009-06-30 2010-06-25 복분자 추출물을 함유하는 피부 주름 개선용 화장료 조성물

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/004144 A-371-Of-International WO2011002179A2 (ko) 2009-06-25 2010-06-25 복분자 추출물을 함유하는 피부 주름 개선용 화장료 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/778,176 Division US9198945B2 (en) 2009-06-25 2013-02-27 Cosmetic compositoin containing a rubus coreanus extract for diminishing skin wrinkles

Publications (1)

Publication Number Publication Date
US20120107431A1 true US20120107431A1 (en) 2012-05-03

Family

ID=43411567

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/381,784 Abandoned US20120107431A1 (en) 2009-06-25 2010-06-25 Cosmetic composition containing a rubus coreanus extract for diminishing skin wrinkles
US13/778,176 Active 2030-08-22 US9198945B2 (en) 2009-06-25 2013-02-27 Cosmetic compositoin containing a rubus coreanus extract for diminishing skin wrinkles

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/778,176 Active 2030-08-22 US9198945B2 (en) 2009-06-25 2013-02-27 Cosmetic compositoin containing a rubus coreanus extract for diminishing skin wrinkles

Country Status (6)

Country Link
US (2) US20120107431A1 (ko)
JP (1) JP5889185B2 (ko)
KR (1) KR101736775B1 (ko)
CN (1) CN102470096B (ko)
HK (1) HK1168799A1 (ko)
WO (1) WO2011002179A2 (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11224564B2 (en) 2018-06-29 2022-01-18 Hoseo University Academic Cooperation Foundation Composition comprising erigeron annuus flower essential oil for prevention and treatment of neuromuscular disease
US11958897B2 (en) 2018-08-23 2024-04-16 Hauul Bio Anti-VAMP2 antibody for inhibiting snare complex and use thereof

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5259710B2 (ja) * 2007-07-10 2013-08-07 メディ‐トックス、インク． ボツリヌス毒素の安定性が改善された薬学的液状組成物
CN103110560A (zh) * 2012-12-14 2013-05-22 吴江市德佐日用化学品有限公司 一种修复型护手霜的制备方法
KR101314680B1 (ko) * 2013-01-04 2013-10-04 주식회사 다솔 복분자 파우더를 함유한 화장품 조성물
US9480731B2 (en) * 2013-12-12 2016-11-01 Medy-Tox, Inc. Long lasting effect of new botulinum toxin formulations
KR20240023684A (ko) 2016-09-13 2024-02-22 알레간 인코포레이티드 안정화된 비단백질 클로스트리듐 독소 조성물
KR102249419B1 (ko) * 2018-11-15 2021-05-07 김영배 복분자유를 유효성분으로 함유하는 피부장벽 기능 개선용 조성물
KR102310943B1 (ko) 2019-05-16 2021-10-07 재단법인 포항테크노파크 산딸기 추출물 분말 및 산딸기씨 분말을 함유하는 바디 스크랩 화장료 조성물의 제조방법
KR102297991B1 (ko) 2019-10-11 2021-09-07 주식회사 하울바이오 SNARE 복합체를 억제하는 항-Syntaxin 1A 항체 및 이의 용도
KR102274841B1 (ko) 2019-10-16 2021-07-12 주식회사 하울바이오 Snare 복합체를 억제하는 항-snap 25 항체 및 이의 용도
KR102367726B1 (ko) * 2019-11-01 2022-02-25 동신대학교산학협력단 미성숙 복분자 추출물을 이용한 피부 주름 개선용 조성물
KR102561292B1 (ko) 2022-05-20 2023-07-27 한도숙 피부 투과성을 향상시킨 신경전달물질 펜타펩타이드를 포함하는 주름 개선용 화장료 조성물 및 이의 제조방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030152545A1 (en) * 2000-12-01 2003-08-14 Park Hyo Suk Topical liquid composition for promoting hair growth and process of manufacturing thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0873342A (ja) * 1994-09-05 1996-03-19 Ichimaru Pharcos Co Ltd 覆盆子抽出物含有皮膚外用剤または浴用剤
JP2002241299A (ja) * 2001-02-13 2002-08-28 Ichimaru Pharcos Co Ltd メイラード反応修復剤
CN1245953C (zh) * 2004-05-17 2006-03-22 刘贤英 一种中药生物祛皱嫩肤化妆品及其制备工艺
KR100767471B1 (ko) * 2005-10-24 2007-10-17 금산고려홍삼 주식회사 황토와 홍삼 성분이 함유된 미용팩
JP2007186457A (ja) * 2006-01-13 2007-07-26 Ichimaru Pharcos Co Ltd トリプターゼ活性阻害剤およびその利用
JP4800049B2 (ja) * 2006-01-31 2011-10-26 一丸ファルコス株式会社 ｍＴＯＲを活性化する製剤及びｍＴＯＲを活性化する方法
KR100815256B1 (ko) * 2006-07-20 2008-03-19 주식회사 참 존 복분자 발효물 및 이를 포함하는 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030152545A1 (en) * 2000-12-01 2003-08-14 Park Hyo Suk Topical liquid composition for promoting hair growth and process of manufacturing thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11224564B2 (en) 2018-06-29 2022-01-18 Hoseo University Academic Cooperation Foundation Composition comprising erigeron annuus flower essential oil for prevention and treatment of neuromuscular disease
US11958897B2 (en) 2018-08-23 2024-04-16 Hauul Bio Anti-VAMP2 antibody for inhibiting snare complex and use thereof

Also Published As

Publication number Publication date
US20130171282A1 (en) 2013-07-04
JP5889185B2 (ja) 2016-03-22
US9198945B2 (en) 2015-12-01
KR101736775B1 (ko) 2017-05-18
WO2011002179A2 (ko) 2011-01-06
JP2012532097A (ja) 2012-12-13
HK1168799A1 (en) 2013-01-11
KR20110001915A (ko) 2011-01-06
CN102470096A (zh) 2012-05-23
CN102470096B (zh) 2013-12-18
WO2011002179A3 (ko) 2011-05-19

Similar Documents

Publication Publication Date Title
US9198945B2 (en) Cosmetic compositoin containing a rubus coreanus extract for diminishing skin wrinkles
US8101214B2 (en) Composition for skin external application containing complex of herbal extracts
KR101921211B1 (ko) 단풍취 추출물 또는 이의 분획물을 유효성분으로 함유하는 피부 재생용 화장료 조성물
KR102460358B1 (ko) 유산균 발효 허브 혼합 추출물을 함유하는 미백, 주름개선, 자외선 차단, 항아토피 및 무좀 예방 또는 개선 기능성 화장료 조성물
KR102009676B1 (ko) 대나무 발효물을 함유하는 화장료 조성물
KR101825704B1 (ko) 커피 실버스킨 추출물을 유효성분으로 함유하는 화장료 조성물
KR101191140B1 (ko) 장딸기 열매 추출물 및 마유를 함유하는 피부 보호용 화장료 조성물
KR20130010250A (ko) 허니부쉬 추출물 또는 이의 발효액을 유효성분으로 함유하는 피부 주름 개선용 조성물
KR101673226B1 (ko) 편백잎 추출물을 함유하는 피부 주름 개선용 화장료 조성물
JP2000239146A (ja) 化粧料
KR20130102712A (ko) 따나카 발효 추출물을 이용한 열노화 방지 및 피부 개선 조성물
KR20140026819A (ko) 진피 및 우슬의 혼합 추출물을 함유하는 피부장벽강화용 조성물
KR101650020B1 (ko) 스노우베리 추출물을 함유하는 피부 주름 개선용 화장료 조성물
KR100564107B1 (ko) 피부노화방지 효능을 갖는 혼합 식물 추출물을 함유한화장료 조성물
JP2001233727A (ja) 化粧品
KR20090105222A (ko) 모공 축소용 화장료 조성물
KR20190049067A (ko) 커피 실버스킨 및 커피박 추출물을 유효성분으로 함유하는 화장료 조성물
KR100628518B1 (ko) 대두황권 추출물 및 이를 함유하는 피부노화 방지용기능성 화장품
TWI706792B (zh) 臭菘提取物或其餾分的用途
KR102076655B1 (ko) 미세침 분말 및 강황 추출물을 유효성분으로 포함하는 슬리밍용 화장료 조성물
CN113631227A (zh) 抗老化剂、抗氧化剂、抗炎剂、及美白剂、以及化妆品
KR20110081433A (ko) 양마 추출물을 함유하는 피부 외용제 조성물
KR102683512B1 (ko) 피부 주름 방지, 피부 장벽 기능 개선, 탈모 방지, 발모 촉진 및 모발 건강 증진 효과를 갖는 소나무 발효 추출물 제조 방법
KR20160068303A (ko) 음주 후 피부 건조, 피부 트러블 또는 피부 부종 개선용 화장료 조성물
KR20110089626A (ko) 식물 추출물을 포함하는 화장료 조성물

Legal Events

Date Code Title Description
AS Assignment

Owner name: AMOREPACIFIC CORPORATION, KOREA, DEMOCRATIC PEOPLE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KIM, DONG HYUN;PARK, JUN SEONG;YU, SUN HYE;AND OTHERS;REEL/FRAME:027463/0285

Effective date: 20111212

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION